R. Dubbelman

发表

Age-dependent vitamin D status and vertebral condition of white women living in Curaçao (The Netherlands Antilles) as compared with their counterparts in The Netherlands.

F. Muskiet, R. Dubbelman, J. Jonxis, 1993, The American journal of clinical nutrition.

Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials.

N. Aaronson, M. Muller, C. Koning, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Postoperative chemoradiotherapy in gastric cancer – a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy

H. Bartelink, M. Verheij, H. Boot, 2007, British Journal of Cancer.

Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer

F. Hoebers, B. Slotman, S. Zerp, 2015, Radiation Oncology.

Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.

H. van Tinteren, H. Tinteren, J. Wagstaff, 1993, British Journal of Cancer.

Dose-finding studies with carboplatin, ifosfamide, etoposide, and mesna in non-small cell lung cancer.

J. Wanders, J. Mcvie, N. van Zandwijk, 1990, Seminars in oncology.

Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumours.

H. Bartelink, H. Sindermann, J. Schellens, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Perspectives in Horne Care

R. Dubbelman, 1990 .

Perspectives in Home Care

R. Dubbelman, S. Israels, 1990 .

Treatment of patients with IVCS and gross oedema and ascites with diuretic combination and ACE-inhibitors: relation to baseline PRA and PAC.

A. V. van Vliet, R. Dubbelman, W. T. ten Bokkel-Huinink, 1995, The Netherlands journal of medicine.

Urinary and fecal excretion of topotecan in patients with malignant solid tumours

J. Schellens, H. Rosing, J. Beijnen, 2002, Cancer Chemotherapy and Pharmacology.

Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.

A. Hart, A. Begg, B. Floot, 1988, Cancer research.

Reconstitution of interleukin-2

S. Rodenhuis, A. Hekman, E. Rankin, 1990, The Lancet.

Formation of interaction products of carboplatin with DNA in vitro and in cancer patients.

A. Begg, B. Floot, L. den Engelse, 1991, British Journal of Cancer.

Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer Institute.

S. Rodenhuis, O. Dalesio, A. V. van Oosterom, 1992, Seminars in oncology.

Phase I study and pharmacokinetics of intraperitoneal carboplatin.

J. Mcvie, W. van der Vijgh, W. W. ten Bokkel Huinink, 1985, Cancer treatment reviews.

Feasibility and pharmacokinetics of intraperitoneal suramin in advanced malignancy

S. Rodenhuis, J. Beijnen, W. Moolenaar, 2000, Cancer Chemotherapy and Pharmacology.

Complications of Tenckhoff catheter implantation in patients with multiple previous intraabdominal procedures for ovarian carcinoma.

A. Hart, P. D. de Graaf, W. W. ten Bokkel Huinink, 1988, Gynecologic oncology.

UvA-DARE Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer

F. Hoebers, B. Slotman, S. Zerp, 2015 .

Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer.

H. Bartelink, J. Stroom, M. Verheij, 2007, International journal of radiation oncology, biology, physics.

Phase I and pharmacologic study of weekly doxorubicin and 1 h infusional paclitaxel in patients with advanced breast cancer.

J. Schellens, H. Rosing, J. Beijnen, 1998, Anti-cancer drugs.

Feasibility study of high-dose carboplatin and etoposide in the salvage treatment of testicular cancer.

S. Rodenhuis, J. Wanders, D. Richel, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical pharmacokinetics of mitoxantrone after intraperitoneal administration

J. Mcvie, W. W. Bokkel Huinink, R. Dubbelman, 2004, Cancer Chemotherapy and Pharmacology.

Docetaxel alternating with epirubicin and cyclophosphamide: a feasibility study in breast cancer patients.

S. Rodenhuis, W. W. ten Bokkel Huinink, A. Hiemstra, 1997, European journal of cancer.

Phase I trial of N-methylformamide.

J. Mcvie, G. Simonetti, W. W. ten Bokkel Huinink, 1984, Cancer treatment reports.

Pharmacokinetics of carboplatin after intraperitoneal administration

J. Mcvie, W. W. Bokkel Huinink, W. J. Vijgh, 2004, Cancer Chemotherapy and Pharmacology.

Successful intraperitoneal suramin treatment of peritoneal mesothelioma.

S. Rodenhuis, J. Beijnen, W. Moolenaar, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours.

J. Schellens, H. Rosing, J. Beijnen, 2002, European journal of cancer.

Phase I study of mitozolomide on a once daily for 5 days schedule

J. Schornagel, J. Mcvie, W. W. Huinink, 1990, Cancer Chemotherapy and Pharmacology.

Toxicity grading systems

N. Aaronson, B. Taal, I. Mandjes, 1992 .

Long-term venous access with a Hickman catheter: complications and patient satisfaction.

F. V. van Dam, P. D. de Graaf, R. Dubbelman, 1990, The Netherlands journal of surgery.

Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator.

S. Rodenhuis, R. Dubbelman, R. Kröger, 1993, Thorax.

Experimental and clinical results with intraperitoneal cisplatin.

J. Mcvie, W. W. ten Bokkel Huinink, H. Franklin, 1985, Seminars in oncology.

Carboplatin and paclitaxel in patients with advanced ovarian cancer: a dose-finding study.

S. Rodenhuis, O. Dalesio, J. Beijnen, 1997, Seminars in oncology.

A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer.

H. Bartelink, M. Verheij, T. Crosby, 2007, International journal of radiation oncology, biology, physics.

Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy.

M. Verheij, H. Boot, E. Jansen, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer

F. Hoebers, B. Slotman, S. Zerp, 2015, Radiation oncology.

Postoperative chemoradiotherapy in gastric cancer – a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy

H. Bartelink, M. Verheij, H. Boot, 2007, British Journal of Cancer.

Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer

F. Hoebers, B. Slotman, S. Zerp, 2015, Radiation Oncology.

Extravasation of topotecan, a report of two cases

J. Beijnen, M. Schot, L. V. van Warmerdam, 1997 .